Loading clinical trials...
Loading clinical trials...
to evaluate the safety and efficacy of GR1803 in the treatment of patients with systemic lupus erythematosus
Bring this clarity to your next appointment.
Keep all your medical notes and next steps in one place.
Lead Sponsor
Genrix (Shanghai) Biopharmaceutical Co., Ltd.
NCT06599658 · COVID 19, Influenza, and more
NCT07305116 · Autoimmune Diseases, Systemic Lupus Erthematosus (SLE), and more
NCT06828042 · Systemic Lupus Erthematosus, Systemic Sclerosis (SSc), and more
NCT06642870 · Systemic Lupus Erthematosus, Systemic Vasculitis, and more
NCT07456358 · Neurological Diseases, Auto Immune Disease
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
Wuhan, Hubei
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions